Topic: Metastatic Renal Cell Carcinoma
A Special Issue of Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)
Submission deadline: 31 Dec 2021
Guest Editor(s)
Special Issue Introduction
Chapter I. SYSTEMIC THERAPIES
Systemic Therapy for Metastatic Renal-Cell Carcinoma
Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma
Advances in second-line targeted therapies for metastatic renal cell carcinoma
Immunotherapy for metastatic renal cell carcinoma
Management of Bone metastases of RCC: bone targeted treatment, radiotherapy
Treatment/ management of non-ccRCC
Chapter II. MOLECULAR EN BIOMARKERS
An Update on Predictive Biomarkers in Metastatic Renal Cell Carcinoma
The Identification of Key Gene Expression Signature and Biological Pathways in Metastatic Renal Cell Carcinoma
Individualized therapy for metastatic renal cell carcinoma
Targeted genomic landscape of metastases compared to primary tumours in clear cell metastatic renal cell carcinoma
Chapter III. SURGERY
Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma
Overview of adjuvant trials
About value of metastasectomy
Chapter IV. Other
The landscape of contemporary clinical trials for untreated metastatic clear cell renal cell carcinoma
Imaging for Metastatic Renal Cell Carcinoma
Real-world outcomes of the treatment of metastatic renal cell carcinoma
Systemic Therapy for Metastatic Renal-Cell Carcinoma
Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma
Advances in second-line targeted therapies for metastatic renal cell carcinoma
Immunotherapy for metastatic renal cell carcinoma
Management of Bone metastases of RCC: bone targeted treatment, radiotherapy
Treatment/ management of non-ccRCC
Chapter II. MOLECULAR EN BIOMARKERS
An Update on Predictive Biomarkers in Metastatic Renal Cell Carcinoma
The Identification of Key Gene Expression Signature and Biological Pathways in Metastatic Renal Cell Carcinoma
Individualized therapy for metastatic renal cell carcinoma
Targeted genomic landscape of metastases compared to primary tumours in clear cell metastatic renal cell carcinoma
Chapter III. SURGERY
Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma
Overview of adjuvant trials
About value of metastasectomy
Chapter IV. Other
The landscape of contemporary clinical trials for untreated metastatic clear cell renal cell carcinoma
Imaging for Metastatic Renal Cell Carcinoma
Real-world outcomes of the treatment of metastatic renal cell carcinoma
Submission Deadline
31 Dec 2021
Submission Information
For Author Instructions, please refer to https://www.oaepublish.com/jcmt/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=jcmt&SpecialIssueId=498
Submission Deadline: 31 Aug 2020
Contacts: Orla Meng, Managing Editor, olivia@jcmtjournal.com
